Clare Ozawa
InvestorManaging Director at Versant Ventures · Board director at Jengu Therapeutics, Inc. · Board director at Lycia Therapeutics · Board director at Mistral Therapeutics
San Diego, California
Writes $100K – $5M checks · typically $1.5M
About
Clare Ozawa combines a Stanford Ph.D. with experience as COO/CBO at Inception Sciences, leads San Diego–Bay Area investments and sits on boards of Capsida, Lycia, Gate Bioscience and 858 Therapeutics.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Board director at Jengu Therapeutics, Inc.
Intro paths
In turn, Clare can intro founders to Jengu Therapeutics, Inc.'s investors below.
Jengu Therapeutics, Inc.'s investors · 1
Board director at Lycia Therapeutics
Intro paths
In turn, Clare can intro founders to Lycia Therapeutics's investors below.
Lycia Therapeutics's investors · 11
Board director at Mistral Therapeutics
Intro paths
In turn, Clare can intro founders to Mistral Therapeutics's investors below.
Mistral Therapeutics's investors · 1
Experience
- Versant VenturesManaging Directorcurrent2017 — present
- Inception SciencesChief Operating Officer, Chief Business Officer2011 — 2018
- Versant VenturesInvestment Professional2008 — 2010
- Versant EuroVenturesVP Business Development & Licensing2008 — 2010
- NovartisAssistant to CEO Pharma2006 — 2008
- McKinsey & CompanyEngagement Manager2002 — 2006
Skills & more
+6 more
HealthcareLife SciencesStrategic PlanningStrategyManagementPharmaceutical IndustryFrom Clare's professional profile.
Deals · 6
Lycia TherapeuticsBoard seat
via Versant Ventures · filed Jun 2026 · $75M raise
858 Therapeutics, Inc.Board seat
via Versant Ventures · filed Jul 2024 · $50.4M raise
Presbyopia TherapiesBoard seat
via Versant Ventures · filed Mar 2023 · $83.5M raise
March Therapeutics, Inc.Board seat
via Versant Ventures · filed Sep 2022 · $30.3M raise
Jengu Therapeutics, Inc.Board seat
via Versant Ventures · filed Sep 2020 · $50M raise
Mistral TherapeuticsBoard seat
via Versant Ventures · filed Jun 2018 · $59.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Versant Ventures
Network5
Investors connected to Clare in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Clare Ozawa?
- Clare Ozawa combines a Stanford Ph.D. with experience as COO/CBO at Inception Sciences, leads San Diego–Bay Area investments and sits on boards of Capsida, Lycia, Gate Bioscience and 858 Therapeutics.
- Where does Clare Ozawa work?
- Clare Ozawa is Managing Director at Versant Ventures and Board director at Jengu Therapeutics, Inc. and Board director at Lycia Therapeutics and Board director at Mistral Therapeutics.
- What does Clare Ozawa invest in?
- Clare Ozawa invests in Biotech, Healthtech, Medical Devices.
- What check size does Clare Ozawa write?
- Clare Ozawa typically writes checks of $100K – $5M.
- What boards does Clare Ozawa sit on?
- Clare Ozawa holds tracked board seats at 858 Therapeutics, Inc., Jengu Therapeutics, Inc., Lycia Therapeutics, March Therapeutics, Inc., Mistral Therapeutics, Presbyopia Therapies.
- Where did Clare Ozawa go to school?
- Clare Ozawa studied at Stanford University School of Medicine (PhD, Neurosciences); Stanford University (B.S., Biological Sciences).
Same school
Also attended Stanford University School of Medicine83
+ 77 more
Also attended Stanford University2,000
+ 1,994 more
Shared employers
Also worked at Versant Ventures31
+ 25 more
Also worked at Novartis130
+ 124 more
Also worked at McKinsey & Company1,547
+ 1,541 more